From April 2nd to 3rd, the 5th CGT Asia 2024 Innovation Summit on Cell and Gene Therapy was successfully held in Shanghai. This summit gathered 6,616 professional guests from 2,539 well-known enterprises across 15 different countries. With a professional perspective focused on promoting the integration of upstream and downstream industries and the translation of scientific achievements, participants engaged in in-depth discussions on topics of high concern to industry experts, such as the layout of industrialization and commercialization modules for cell therapy, and the breakthroughs in viral vector application technologies, collectively empowering the deep development of the industry.In the selection of "CGT Awards - 2024 Asia Pacific Cell and Gene Therapy Industry Star Awards", Shenzhen Cell Valley won the "Best Technological Breakthrough Award" by virtue of overcoming the core technology restricting production capacity and cost in cell therapy — retroviral vector technology, as well as its groundbreaking progress in scientific research and clinical practice.

Cell and Gene Therapy (CGT) is a major strategic development direction for the nation and represents the most promising research field for benefiting patients with refractory diseases globally. With continuous technological innovation and policy support, the CGT industry continues to grow, gradually entering a golden era. Strengthening original and leading research, and tackling key core technologies, will become a crucial accelerator for the industry's development.Leveraging its profound technical foundation, leading scientific research strength, and unremitting pioneering spirit, Deep Harbour Cell Valley will continue to strengthen the collaborative linkage among industry, academia, research, and application. The company is committed to promoting achievement translation and clinical applications, working jointly with domestic and international medical institutions to comprehensively develop Investigator-Initiated Trials (IIT) clinical cell therapy centers. By creating a new model for precision medicine treatment, Deep Harbour Cell Valley aims to make even greater contributions to the cause of human health.